Brief: Mauna Kea Technologies Says Cellvizio Receives Positive Evaluation From Korean Health Authority
March 15 (Reuters) - MAUNA KEA TECHNOLOGIES SAS MKEA.PA :
* ANNOUNCES CELLVIZIO RECEIVES POSITIVE EVALUATION FROM
KOREAN
HEALTH AUTHORITY
* RECOGNITION LEADS TO THE CREATION OF SPECIFIC
REIMBURSEMENT
CODES FOR CELLVIZIO PROCEDURES IN SOUTH KOREA
Source text for Eikon: ID:nBw5qLq7Ja
Further company coverage: MKEA.PA
(Gdynia Newsroom:)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Mauna Kea Technologies SA
See all newsBrief: Mauna Kea Technologies Confirms Trajectory Toward Profitability By Year-End 2027
Brief: Mauna Kea Technologies Announces Results Of Its Combined General Meeting
French and Benelux stocks-Factors to watch 21 Nov
Brief: Mauna Kea Technologies Receives NMPA Regulatory Approval In China For Its Next-Generation Cellvizio Platform
Europe Research Roundup: Craneware, Croda, Genus